4.8 Article

Circulating phospholipid profiling identifies portal contribution to NASH signature in obesity

期刊

JOURNAL OF HEPATOLOGY
卷 62, 期 4, 页码 905-912

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jhep.2014.11.002

关键词

Lipidomics; Visceral adipose tissue; Glycerophosphatidylglycerols; Glycerophosphatidylethanolamines; Bariatric surgery

资金

  1. Assistance Publique-Hopitaux de Paris (APHP)
  2. Direction of Clinical Research
  3. Programme Hospitalier de Recherche Clinique [AOR 02076]
  4. European Commission [LSHM-CT-2005-018734]
  5. European Union [Health-F2-2009-241762]
  6. Societe Francaise de Nutrition (SFN)

向作者/读者索取更多资源

Background & Aims: Non-alcoholic steatohepatitis (NASH) is characterized by steatosis, lobular inflammation, hepatocyte ballooning with fibrosis in severe cases, and high prevalence in obesity. We aimed at defining NASH signature in morbid obesity by mass spectrometry-based lipidomic analysis. Methods: We analyzed systemic blood before and 12 months after bariatric surgery, along with portal blood and adipose tissue lipid efflux collected from obese women at the time of surgery (9 structural classes, 150 species). Results: Increased concentrations of several glycerophosphocholines (PC), glycerophosphoethanolamines (PE), glycerophosphoinositols (PI), glycerophosphoglycerols (PG), lyso-glycerophosphocholines (LPC), and ceramides (Cer) were detected in systemic circulation of NASH subjects. Post-surgery weight loss (12 months) improved the levels of liver enzymes, as well as several lipids, but most PG and Cer species remained elevated. Analysis of lipids from hepatic portal system at the time of surgery revealed limited lipid alterations compared to systemic circulation, but PG and PE classes were found significantly increased in NASH subjects. We evaluated the contribution of visceral adipose tissue to lipid alterations in portal circulation by measuring adipose tissue lipid efflux ex vivo, and observed only minor alterations in NASH subjects. Interestingly, integration of clinical and lipidomic data (portal and systemic) led us to define a NASH signature in which lipids and clinical parameters are equal contributors. Conclusions: Circulatory (portal and systemic) phospholipid profiling and clinical data defines NASH signature in morbid obesity. We report weak contribution of visceral adipose tissue to NASH-related portal lipid alterations, suggesting possible contribution from other organs draining into hepatic portal system. (C) 2015 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据